HAMLET B — Hamlet BioPharma AB Cashflow Statement
0.000.00%
- SEK1.12bn
- SEK1.12bn
Annual cashflow statement for Hamlet BioPharma AB, fiscal year end - June 30th, millions except per share.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | |||||
Standards: | — | — | — | — | — |
Status: | fx Preliminary | fx Preliminary | fx Preliminary | fx Preliminary | fx Preliminary |